Cerenome Reports Third Quarter 2026 Financial Results and Business Highlights Featuring REYOBIQ ReSPECT- LM Data and CNSide Commercial and Reimbursement Progress
HOUSTON, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) (“Cerenome” or the “Company”), a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted radiopharmaceuticals, and artificial intelligence, announces financial results for the third quarter ended September 30, 2026, and provides an overview of recent business progress.
HOUSTON, Nov. 13, 2026 (GLOBE NEWSWIRE) -- Cerenome, Inc. (Nasdaq: CNSY) (“Cerenome” or the “Company”), a CNS oncology company advancing an integrated platform that combines precision diagnostics, targeted radiopharmaceuticals, and artificial intelligence, announces financial results for the third quarter ended September 30, 2026, and provides an overview of recent business progress.
NEW YORK, Nov. 13, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fluence Energy, Inc. (NASDAQ: FLNC) between November 24, 2025 and September 16, 2026, inclusive (the “Class Period”), of the important November 30, 2026 lead plaintiff deadline. ...
NEW YORK, Nov. 13, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of NuScale Power Corporation (NYSE: SMR) between February 27, 2026 and September 10, 2026, inclusive (the “Class Period”). A class action lawsuit has already been filed. If… ...
ניו יורק, Nov. 14, 2026 (GLOBE NEWSWIRE) -- מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מודיע על תביעה ייצוגית בשם רוכשי ניירות ערך של NuScale Power Corporation (NYSE: SMR) בין התאריכים 27 בפברואר 2026 עד 10 בספטמבר 2026, שני התאריכים כוללים ("תקופת התביעה הייצוגית"). כבר הוגשה תביעה ייצוגית. אם ברצונכם… ...